Poster assignment list - Association of Medical Microbiology and

POSTER PRESENTATION INSTRUCTIONS
POSTER Viewing:
Location:
Thursday, April 16 and Friday, April 17
Coles Ballroom (PEI Convention Centre)
Viewing Times Thursday April 16:
• Morning break 11:00 am to 12:30 pm
o STUDENT POSTER PRESENTERS (SP) MUST
BE AT THEIR POSTERS TO ANSWERS
QUESTIONS!
• Lunch between 12:30 pm to 1:00 pm
• Welcome Reception 6:30 pm to 8:30 pm
Viewing Times Friday April 17:
• Morning break 11:00 am to 12:30 pm
o POSTER PRESENTERS (P) MUST BE AT
THEIR POSTERS TO ANSWERS
QUESTIONS!
• Lunch between 12:30 pm to 1:00 pm
Poster Set-Up Time:
• Wednesday April 15 between 4:00 pm – 6:00 pm
• Thursday April 16 between 7:00 am – 10:00 am
Poster Removal Time:
• Friday April 17 at 1:00 pm
* Should you require assistance onsite, please go to the Registration Desk.
GENERAL INFORMATION
• Poster Boards are 4ft high x 8ft wide.
• A good poster size is 3ft high x 6ft wide.
• Velcro (male side) and pin friendly.
All presenting authors MUST be registered for the annual conference, no later than Monday March 2, 2015. If
registration is not complete by this date, the abstract will be REMOVED and will NOT be published.
STUDENT POSTER Presenters must fill in and submit to ([email protected]) a
Student/Technologist/Trainee Awards Competition Form by Monday March 2, 2015.
http://ammi.ca/media/75949/Student-Technologist-Trainee%20Award%20Form%20-%20EN%20v2.pdf
HOTEL AND CONFERENCE REGISTRATION INFORMATION
The host hotel for the conference is the Delta Prince Edward. Registration is also available at the Holman Grand
Hotel. The room block release date is Monday, March 9, 2015.
To register at Delta Prince Edward ($179.00 per night + taxes):
https://www.deltahotels.com/Groups/Delta-Prince-Edward-Groups/AMMI-Canada-CACMID-Annual-Conference-2015
To register at the Holman Grand Hotel ($189.00 per night + taxes):
https://bookings.ihotelier.com/The-Holman-GrandHotel/bookings.jsp?hotelId=75665&GroupID=1284095
Early Bird conference registration cut off is March 2, 2015! Register now and receive a $100.00 off your full conference
registration. Just fill in your reservation number during the registration process. Offer valid while rooms are available.
Register now: http://ammi.emsreg.com/ammi15/public/splash1.aspx
Serial No. Prog. No.
0003 SP01
0004 SP02
0007 SP03
0021 SP04
0026 SP05
0028 SP06
0031 SP07
0035 SP08
0036 SP09
0040 SP10
0045 SP11
0046 SP12
0047 SP13
0048 SP14
0049 SP15
0051 SP16
0052 SP17
0056 SP18
0058 SP19
0060 SP20
STUDENT POSTER PRESENTATION ASSIGNMENT LIST
Initial Last name
Title
B.
GHADAKI
COPD Symptom and Disease Screening in an HIV Population
H.
MIHIRETIE
Intestinal Parasitosis in Relation to CD4+T Cells Levels and Anemia
among HAART Initiated and Non-HAART Initiated Pediatric HIV
Patients in Zewditu Memorial Hospital, Addis Ababa, Ethiopia
G.
CHAN
Characterization of Canadian Hospital Infection Control Practices for
Caregivers and Visitors
C.
LATA
Antimicrobial Prescribing Practices in the Treatment of Suspected UTI
in the Elderly in the Emergency Department: a Retrospective Single
Centre Study
H.Y.
ZHOU
The Infectiousness and/or Virulence of Isoniazid-Resistant vs.
Susceptible Pulmonary Tuberculosis: A Case-Control Study in Alberta
R.
FATTOUH
Meropenem MIC Profile of Carbapenemase Producing
Enterobacteriaceae in a Low Prevalence Region
N.
RAJAPAKSE
Creation of A Novel Pediatric Antimicrobial Stewardship Advanced
Fellowship Training Program
R.
PRIYANTHA
Emerging Antimicrobial Resistance among Staphylococcus
Pseudintermedius, a Potential Zoonoses of Canine Origin
A.
BAI
Positive Impact of Infectious Disease Consultation on Quality of Care,
Mortality and Length of Stay in Staphylococcus aureus Bacteremia:
Results from a Large Multicenter Cohort Study
C.
PENNEY
Prospective Observational Study of Diagnosis of Urinary Tract
Infection and Response to Therapy in Long Term Care
J.
CHONG
Molecular Epidemiology of Vancomycin Heteroresistant CoagulaseNegative Staphylococci in a Neonatal Intensive Care Unit in Quebec
S.
LOTHER
Increasing Incidence of Group C and Group G Streptococcal
Bacteremia Attributed to Increased Bacterial Virulence Factors and
Poor Outcomes
M.
ROSTOM
Antimicrobial Stewardship in Primary Care: An Evaluation of the
Management of Acute Uncomplicated Cystitis in a Family Health
Team
B.
BURSTEIN
Emergency Department Utilization of Respiratory Virus Testing for
Febrile Young Infants Under Six Weeks of Age
M.
ALGHOUNAIM Clostridium difficile Infections (CDI) in Children: Are we
overestimating rates just because of the diagnostic method used?
S.
FATHIMA
Surveillance of Human Parainfluenza Types 1-4 and Association with
Acute Lower Respiratory Tract Infections in Hospitalized Cases,
Alberta, Canada (2010 – 2013)
N.
ZELYAS
Clostridium difficile infection in solid organ transplant recipients at a
tertiary care centre during 2006-2013
C.
BOIKOS
Safety of the Live-Attenuated Intranasal Influenza Virus (LAIV)
Vaccine in Children and Adolescents with Cystic Fibrosis and their
Healthy Siblings
J.
ZHANG
Severe Skin Lesions Induced by a Predominant CA-MRSA Strain
USA300 are Associated with a Unique Neutrophil Response and
Involvement of Proteinase Activated Receptors (PARs)
É.
FORTIN
Surveillance of Antimicrobial Use in Québec Acute Care Hospitals: A
Revised February 24, 2015
Page 2 of 6
Serial No.
Prog. No.
Initial Last name
0065 SP21
K.
POPIEL
0066 SP22
D.
WHELLAMS
0068 SP23
G
SHUMILAK
0073 SP24
Y.
CHEN
0077 SP25
C.
LE
0078 SP26
L.
GOODLIFFE
0080 SP27
D.R.
MACFADDEN
0082 SP28
L.
RYAN
0084 SP29
A.
DENISUIK
0085 SP30
S.
0086 SP31
0089 SP32
Y.
S.
DE L’ÉTOILEMOREL
EMOND
SURESH
0090 SP33
S.
MASUD
0091 SP34
E.
KOECK
0092 SP35
A.
MCFARLANE
0094 SP36
G.
POMERANZ
0098 SP37
D.
HARRIS
0100 SP38
0101 SP39
E.
A.
VALLIERES
DELORME
0103 SP40
H.
AL SIDAIRI
0150 SP41
C.
MARTINEZ DE
LA PENA
Title
Dream or Almost Reality?
Usefulness of Fecal Calprotectin and Serum Procalcitonin in
Predicting a Positive C. difficile Toxin Gene Polymerase Chain
Reaction Assay
Successful use of intrathecal colistin in a case of Pseudomonas
aeruginosa ventriculitis: a case report and brief review of the
literature
Prevalence of Anemia in the Saskatchewan Population with HIV
Infection
Rapid Identification of Bacteria in Positive Blood Cultures Using
Smudge Plate Preparation and MALDI-TOF MS System
Assessment of the management of suspected urinary tract infections
for identification of targeted antimicrobial stewardship interventions
Clinical Features and Outcomes of Influenza Infection in Community
Dwelling Older Adults Presenting to Six Urban Emergency
Departments
Engaging Infectious Diseases And Microbiology Residents in
Improving the Value of Healthcare: Choosing Wisely
Incidence and Outcomes of Hospital-acquired C. difficile Infection at a
Large Community Hospital Before and After a Multipronged
Prevention and Management Initiative
The Continued Rise of Extended-Spectrum β-Lactamase-Producing
Escherichia coli in Canadian Hospitals: CANWARD 2007-2013
Inpatient Care of Community Acquired Pneumonia: Opportunities for
Improvement
Feasibility of UV-C light disinfection in a Canadian hospital.
Non-Polio Enterovirus Types Associated with Acute Flaccid Paralysis –
A Systematic Review
Evaluation of Matrix Assisted Laser Desorption Ionization-Time of
Flight Mass Spectrometry (MALDI-TOF MS) for Yeast Identification
Xpert MTB/RIF as a Supplemental Test to Acid-Fast Bacilli Sputum
Microscopy in the Diagnosis of Tuberculosis: Potential Resource
Savings
Hospitalized Influenza Patients during 2013-2014; a Comparison of
ICU and Ward Treated Patients including Antimicrobial Therapy,
Adverse Events, and Outcomes
Clinical Spectrum of Rhinovirus Infections in Hospitalized Children in
Israel - a single center's experience
Prosthetic Joint Infections: Patterns of Practice for Diagnosis,
Management, and Outcome
Urinary Biomarkers in Patients with Cystic Fibrosis
Carbon Source Modulates Paradoxical Growth Effect of Caspofungin
in Candida albicans
Cost-effectiveness of MALDI- TOF MS in Clinical Analysis of Urine
Specimens in Nova Scotia
Role of Type IV Pili in the Clostridium difficile Pathogenic Program
Revised February 24, 2015
Page 3 of 6
Serial No. Prog. No.
0121 SP42
Initial Last name
B.
BERENGER
0125 SP43
A.
MA
0127 SP44
D.
JEONG
0131 SP45
A.
LAWANDI
0137 SP46
C.
LAM
0139 SP47
A.
CAMPIGOTTO
0144 SP48
G.
SHAH
0145 SP49
W.J.
CONNORS
Title
Detection and Characterization of a 2014 Escherichia coli O157:H7
Outbreak in Alberta by Multiple Molecular Methods Including Whole
Genome Sequencing
Heat Resistant Shiga Toxin-Producing Escherichia coli (STEC) from
Clinical Cases in Alberta
The Use of Antibiotics in the Treatment of Skin and Soft Tissue
Infections in Selected First Nations Communities
The Role of Inter-Hospital Sample Transport in Total Assay Time for
Microbiological Screening Tests
Investigation of Matrix Assisted Laser Desorption/Ionisation Time-ofFlight Mass Spectrometry (MALDI-TOF-MS) for detection of
Clostridium difficile toxin A and B from stool samples
Cumulative antimicrobial susceptibility data from ICUs at one
institution: should data be combined?
Infectious Complications After Central Venous Catheter Repair in
Pediatric Patients
Acute Odontogenic Infection Management in the OPAT Clinic Setting:
a Quality Improvement Study in Calgary, Alberta
Revised February 24, 2015
Page 4 of 6
Serial No. Prog. No.
0005 P01
0006 P02
0011 P03
0015 P04
0017 P05
0022 P06
0029 P07
0033 P08
0037 P09
0039 P10
0041 P11
0043 P12
0044 P13
0053 P14
0054 P15
0055 P16
0118 P17
0149 P18
0072 P19
0097 P20
POSTER PRESENTATION ASSIGNMENT LIST
Initial Last name
Title
N.
AL MUSAYEIB Antiprotozoal potential of phenolic compounds from Kleinia odora
A.
SHEPHARD
In-vitro Antiviral Action of Amylmetacresol (AMC) and 2,4Dichlorobenzyl Alcohol (BCDA) Against the Respiratory Pathogen
Parainfluenza Type 3
B.M. WILLEY
Use of Temocillin Resistance (TemR) as a Phenotypic Diffusion Marker
for Class D Carbapenemases (Carb) in Carbapenemase-Producing
Organisms (CPO)
N.L.
GILBERT
Seroconversion for Cytomegalovirus Infection in a Cohort of Pregnant
Women in Quebec, 2010-2013
M.
VALAN ARASU Novel Isosteviol Isolated From Pittosporum tetraspermum Exhibited
Antimicrobial, Antibiofilm And Anticancer Activities
M.
ABIDI
CYP2C19*17 Genetic Polymorphism and Therapeutic Challenges in an
Allogeneic Stem Cell Transplant Recipient with Invasive Pulmonary
Aspergillosis
C.
LAVIGNE
Nanoparticles to Target HIV Reservoirs
M.
MCCONNELL
Increased Recovery and Detection of Pathogens Using Copan’s
WASPLab™ Total Laboratory Automation (TLA)
A.
BAI
Usefulness of previous methicillin-resistant Staphylococcus aureus
screening results in guiding empiric therapy for S. aureus bacteremia
N.
IRFAN
Inadequate Symptom Documentation of Urinary Tract Infection in the
Medical Chart
K.
RANA
All-Oral 12-Week Combination Treatment with Daclatasvir (DCV) and
Sofosbuvir (SOF) in Patients Infected with HCV Genotype (GT) 3:
ALLY-3 Phase 3 Study
E.S.
SWENSON
All-oral, Fixed-dose Combination Therapy with
Daclatasvir/Asunaprevir/BMS-791325 for Non-cirrhotic Patients with
Chronic HCV Genotype 1 Infection: UNITY-1 Phase 3 SVR12 Results
E.S.
SWENSON
All-oral Fixed-dose Combination Therapy with
Daclatasvir/Asunaprevir/BMS-791325, ± Ribavirin, for Patients with
Chronic HCV Genotype 1 Infection and Compensated Cirrhosis:
UNITY-2 Phase 3 SVR12 Results
H. Y.
ZHOU
Recurrent Micafungin-Resistant Candida glabrata Candidemia with
Prolonged Micafungin Treatment for Multiple Intra-abdominal
Abscesses: A Case Report
M-K. LEE
Active Environmental Surveillance of Lyme Disease in British
Columbia (2013 and 2014)
R.
FATTOUH
Investigating the Potential Role of Bacterial Infection in
Granulomatosis with Polyangiitis (GPA)
P. N. LEVETT
Evaluation of antigen detection for confirmatory testing of hepatitis C
virus infection
P.N.
LEVETT
Recurrent Invasive Haemophilus influenzae Serotype a Infection in an
Infant
M.
REHAN
Optimizing the Diagnostic Yield of Joint Fluid/ Tissue Culture for the
Hamilton Regional Laboratory Medicine Program
J.
LEBLANC
Pushing the Limits of Chemistry Point-of-Care Testing for the
Management of Patients under Investigation for Ebola Virus Disease
Revised February 24, 2015
Page 5 of 6
Serial No. Prog. No.
0099 P21
Initial Last name
M.
KISSOON
0109 P22
T.
MAZZULLI
0114 P23
K.
SAVAGE
0062 P24
X-F.
ZENG
0122 P25
S.
WEST
0134 P26
V.
0135 P27
0146 P28
0018 P29
J.
M. L.
K.
MEIERSTEPHENSON
KETTNER
GRAHAM
KADKHODA
0107 P30
R.
ADWAN
Title
Increase in Methicillin-susceptible Staphylococcus aureus with
Reduced Susceptibility to Triclosan Over the Last 20 Years
Characterizing the resistance related mutations in the NS3 protease
of Hepatitis C-infected Ontario patients.
Iron Restriction to Clinical Isolates of Candida albicans by DIBI Inhibits
Growth and Increases Sensitivity to Azole Antifungals
Deletion of DprA RF Domain Attenuates the Virulence of
Streptococcus pneumonia
SNAP—Sepsis Now a Priority: Development and Implementation of a
Sepsis Algorithm in the Emergency Department of an Academic
Hospital
What a Fluke: A Case of Biliary Fascioliasis in a Recent Immigrant
AMR, Public Health, and Knowledge Translation: A Forward Approach
Oversight of Human and Animal Pathogens and Toxins
The Retrospective Study of the Prevalence and Clinical Significance of
Hepatitis B Virus Precore and Basal Core Promoter Variants
Mycoplasma pneumoniae Infection in Children Less Than Five Years
of Age; a 17 Years Review
Revised February 24, 2015
Page 6 of 6